Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

5. Accounts Receivable (Tables)

12 Months Ended

Mar. 31, 2020

	March 31,
	2020			2019
Accounts receivable	$	6,320,000		$	3,948,000
Less: allowance for doubtful accounts		(1,028,000	)		(24,000	)
Less: discounts, rebates, distributor fees and returns		(1,230,000	)		(443,000	)
	$	4,062,000		$	3,841,000